Samuele Ferrari

14PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 11, 2026
The inflammatory "death-to-life" loop in VEXAS syndrome.

|Jun 01, 2026
Selection of human hematopoietic stem cells bearing the intended functional edit by transient AND-gate reporters.

|Apr 16, 2026
VEXAS syndrome.

|Jan 08, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

Martina Spiga, Alessia Potenza, Zulma Magnani

|Apr 16, 2025
Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs.

Mohsen Hosseini, Veronique Voisin, Ali Chegini

|Apr 08, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.

Raffaella Molteni, Martina Fiumara, Corrado Campochiaro

Pageof 3

Frequent Collaborators

10 joint publications

Luigi Naldini

7 joint publications

Martina Fiumara

6 joint publications

Stefano Beretta

6 joint publications

Daniele Canarutto